Dengue fever (DF) and Dengue haemorrhagic fever (DHF) causes worldwide mortality and morbidity concerns. It is estimated that 2.5 billion people are at risk of DF, particularly the 975 million of those living in urban areas in tropical and sub-tropical countries including Southeast Asia1. The World Health Organization (WHO) estimates that there are more than 50 million dengue infections per year including 500,000 hospitalisations for DHF affecting predominantly children1, 2. Dengue cases in Malaysia follows an upward trend with a fourfold increase since the year 2000 to 181 cases per 100,000 populations in 2007, of which 110 of these cases were in children less than 14 years old 3.